Heme Oxygenase-1 in Patients With Interstitial Lung Disease: A Review of the Clinical Evidence
- 12 February 2021
- journal article
- review article
- Published by Elsevier BV in The American Journal of the Medical Sciences
- Vol. 362 (2), 122-129
- https://doi.org/10.1016/j.amjms.2021.02.009
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Identification of a Novel Macrophage Phenotype That Develops in Response to Atherogenic Phospholipids via Nrf2Circulation Research, 2010
- Coronary Intraplaque Hemorrhage Evokes a Novel Atheroprotective Macrophage PhenotypeThe American Journal of Pathology, 2009
- MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary FibrosisPLoS Medicine, 2008
- Acute Exacerbations of Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Matrix Metalloproteases in Aberrant Fibrotic Tissue RemodelingProceedings of the American Thoracic Society, 2006
- The Heme-Bach1 Pathway in the Regulation of Oxidative Stress Response and Erythroid DifferentiationAntioxidants and Redox Signaling, 2006
- Heme oxygenase and heme degradationBiochemical and Biophysical Research Communications, 2005
- Bilirubin: An Endogenous Product of Heme Degradation with Both Cytotoxic and Cytoprotective Properties: Fig. 1Molecular Pharmacology, 2004
- Alternative activation of macrophagesNature Reviews Immunology, 2003